Related Experiment Video
Updated: Jun 18, 2026

Dissection of Adult Mouse Utricle and Adenovirus-mediated Supporting-cell Infection
Published on: March 28, 2012
Blocking pro-cell-death signal pathways to conserve hearing.
Christine T Dinh1, Thomas R Van De Water
1Department of Otolaryngology, Cochlear Implant Research Program, University of Miami Ear Institute, University of Miami, Miller School of Medicine, Miami, FL 33136-1015, USA.
Therapeutic drugs are being developed to prevent hearing loss by protecting auditory hair cells from programmed cell death. Research explores corticosteroids, anti-apoptotic agents like D-JNKI-1, and antioxidants to preserve hearing.
Area of Science:
- Oto-neuroscience
- Pharmacology
- Cell Biology
Background:
- Auditory hair cell death contributes to sensorineural hearing loss.
- Inflammation and apoptosis are key pathways in hair cell damage.
- Current treatments aim to preserve hearing by intervening in these pathways.
Purpose of the Study:
- To review current therapeutic strategies for hearing preservation.
- To evaluate the efficacy of dexamethasone and D-JNKI-1.
- To present findings from ongoing research on hearing conservation.
Main Methods:
- Review of existing literature on hearing loss therapeutics.
- In vitro and in vivo studies of anti-apoptotic drugs (D-JNKI-1, SP600125).
- Preclinical and preliminary clinical evaluation of AM-111.
- Animal studies on antioxidant drugs (sodium thiosulfate, N-acetylcysteine, D-methionine).
Main Results:
- Corticosteroids offer anti-inflammatory and anti-apoptotic benefits for acute hearing loss.
- MAPK/JNK pathway inhibitors (D-JNKI-1, AM-111) show promise in preclinical and early clinical studies.
- Antioxidants reduce oxidative stress and attenuate hearing threshold shifts in animal models.
Conclusions:
- Targeting pro-cell-death pathways is a viable strategy for hearing preservation.
- Dexamethasone and D-JNKI-1 are key agents under investigation.
- Further research is needed to translate promising preclinical results into effective clinical treatments for hearing loss.
Related Concept Videos
The Extrinsic Apoptotic Pathway
Overview of Cell Death
Cell death was observed in the early 19th century, but there was no experimental evidence to prove it. In 1842, Carl Vogt first discovered cell death in a metamorphic toad; however, it was not termed ‘cell death.’ Scientists discovered different cell death pathways only in the 20th century...
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
The Intrinsic Apoptotic Pathway
Unrenewable Cells
Photoreceptors
The retina is composed of several layers and contains specialized cells called photoreceptors. The photoreceptors (rods and cones) change their membrane potential when stimulated by light energy. There are two types of photoreceptors—rods and cones—which differ in the shape of their outer...
Cellular Injury V: Apoptosis and Autophagy

